Aseptic osteomyelitis responding to TNFalpha antagonist therapy in a patient with Crohn's disease.
Aseptic osteomyelitis was diagnosed in a patient with Crohn's disease. This rarely reported manifestation responded to infliximab therapy.
Bret
Johan
J
Department of Rheumatology, Purpan Teaching Hospital, Toulouse, France.
Lemaire
Olivia
O
Prat
Catherine
C
Zabraniecki
Laurent
L
Fournie
Bernard
B
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications*; D006801:Humans; D000069285:Infliximab; D008297:Male; D010019:Osteomyelitis / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab